InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,263.74
(
0.27%
)
Post# of 640607
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

manysevens

Send PM Follow Ignore
Followers 253
Posts 27856
Boards Moderated 8
Alias Born 04/15/2004

manysevens

Re: None

Thursday, 01/26/2006 10:18:24 AM

Thursday, January 26, 2006 10:18:24 AM

Post# of 640607
DNAG Volume Alert - News

Thursday , January 26, 2006 07:00 ET

SARASOTA, FL, Jan 26, 2006 (MARKET WIRE via COMTEX) -- DNAPrint Genomics, Inc. (OTC BB: DNAG) today announced that the Company and Harvard University have entered into a sponsored research and a field-exclusive licensing agreement. Under the agreement, DNAPrint Genomics, Inc. will sponsor further development in the Laboratory for Translational Research (LTR) at Harvard Medical School of a diagnostic test devised in the Laboratory to target early identification of the population at risk of developing vascular diabetic complications. The Company also will conduct work directed toward its eventual commercialization of the test.


People who say it cannot be done should not interrupt the person doing it.


http://www.perry-mansfield.org/index_fl.html

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up